Pilot study of the reducing effect on amyloidosis in vivo by three FDA pre-approved drugs via the Alzheimer's APP 5' untranslated region.

Source:http://linkedlifedata.com/resource/pubmed/id/15974925

Download in:

View as

General Info

PMID
15974925